Immunotherapy has changed the way melanoma is treated. In particular, checkpoint inhibitors are responsible for the increasing survival rate for patients with metastatic melanoma. Help us extend the benefits of immunotherapy to more melanoma patients.
Monthly donations help us plan and allocate resources effectively to advance research and save more lives.
I would like to create a card as part of my donation.
I want to receive the latest cancer immunotherapy news.
Find out if your employer will match your donation:
By clicking I agree to the terms & conditions
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442.Donations are tax-deductible to the fullest extent allowable under the law.